Expanded Access Protocol: Repeated Administration of Nurown® (Autologous MSC-NTF Cells) for the Treatment of ALS Expanded Access Protocol: Repeated Administration of Nurown® (Autologous MSC-NTF Cells) for the Trea ...
Intermediate-size Patient Population Expanded Access Protocol: Repeated Administration of Nurown® (Autologous Mesenchymal Stem Cells Secreting Neurotrophic Factors) for the Treatment of Amyotrophic Lateral Sclerosis (ALS) Intermediate-size Patient Population Expanded Access Protocol: Repeated Administration of Nurown® (A ...